Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Carbon Dioxide Laser in Canada
Total 0 results
Nothing found
Sponsors and Collaborators
Sub-Investigator: Łucja Bieleninik, PhD
Maria de las Mercedes Perez Rodriguez
Saw Swee Hock School of Public Health
MYOR Ltd.
Nelson Mandela Academic Hospital
The Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona
Pharmacy Board of Sierra Leone, Ministry of Health and Sanitation
Pompeyo Stalin Alarcón Vigil
Roongroj Bhidayasiri
Donald B. Kohn, M.D.
Didem OZKAL EMINOGLU
Sociedad Panameña de Hematología
Hospital Governador Celso Ramos
Universidad Mayor de San Simón (UMSS, Bolivia)
Steven B. Kleiboeker
Shaoxing Mashan Street Community Health Service Center
Dr. Jochen Brack
Worabe Comprehensive Specialiazed Hospital
Shenzhen Core Medical Technology CO.,LTD.
Centre Hospitalier du Quebec
View Full List
Medical Conditions
Parental
Control Nausea and Vomiting
Humerus Fracture Displaced Proximal
Pharmacokinetics of Ipragliflozin
Macrocephaly Autism Syndrome
Root Abscess
Malignant Tumor of Urinary System (Disorder)
Inoperable Stage III Non-small Cell Lung Cancer
Poor Medication Adherence
Memory Disorders
Neuroectodermal Tumor
Bladder Recurrence
0.5-14 Year Old Children With Nephroblastoma
Granulomatous Disease, Chronic
Endoscopic Surveillance
Atherosclerosis Coronary Artery With Angina Pectoris
Urinary Bladder Neurogenic Dysfunction
Anticoagulant Prophylaxis/Therapy
Bladder Cancer Recurrent
Small Intestine Cancer
View Full List
Drug Interventions
Everolimus
SAR408701 (Tusamitamab ravtansine)
APG2575 800 mg
Rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
Bupropion Extended Release Oral Tablet
Varenicline Controlled Release 1.2 mg
Elafibranor 80mg
Sparsentan
Cyclosporine A
Salvinorin A
Fibrin Sealant
Campath 1H
FTD regimen
The drug "Rutan 0.1".
Clozapine 100 mg
Vehicle
Ceralasertib
Letrozole
Biphasic insulin aspart 30
Idelalisib
View Full List
CROs by country
Contract Research Organizations in Argentina
Contract Research Organizations in Cambodia
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Ecuador
Contract Research Organizations in Ghana
Contract Research Organizations in Guinea
Contract Research Organizations in Panama
Contract Research Organizations in Papua New Guinea
Contract Research Organizations in Portugal
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Sweden
Contract Research Organizations in Switzerland
Contract Research Organizations in Zambia
CRO list by country
CROs in Mexico
Syneos Health
Althian
ODC
PRA Health Sciences
Fractals Clinical Research
Cohortias
Fortrea
PSI
SGS
AXIS Clinicals
All CROs in Mexico
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe